Anglo American PLC
12 March 2008
Anglo American plc (the "Company")
Registered office: 20 Carlton House Terrace, London, SW1Y 5AN
Registered number: 3564138
DIRECTOR'S / PDMR's INTERESTS
The Company annnounces that it received the following notification on Wednesday
12 March from Maitland Advisory LLP with respect to the interests in the
Company's ordinary shares of US$0.54945 each, of Mr N F Oppenheimer, a
non-executive director of the Company:
"Notification of a transaction in Ordinary Shares of US$0.54945 each ("Ordinary
Shares") of Anglo American plc ("the Company") pursuant to paragraph 3.1.2 of
the Disclosure and Transparency Rules and paragraph 22(c) of the Model Code
1. I have been authorised and instructed by Mr NF Oppenheimer and E
Oppenheimer & Son Holdings Limited ("EOSH") of 9 rue Sainte Zithe,
Luxembourg and E Oppenheimer & Son International Limited ("EOSI") and
Gartland Limited ("Gartland") and Naunton Limited ("Naunton") of Midocean
Chambers, PO Box 805, Road Town, Tortola, British Virgin Islands, on their
behalf to make the following notifications in relation to the transactions
specified below.
2. The information is given to you to discharge the obligations of Mr NF
Oppenheimer and EOSH and EOSI and Naunton under paragraph 3.1.2 of the
Disclosure and Transparency Rules and the obligations of EOSH, EOSI and
Naunton under paragraph 22(c) of the Model Code.
3. Mr NF Oppenheimer is a director of the Company and accordingly is a person
discharging managerial responsibilities in relation to the Company. EOSH,
EOSI and Naunton are connected with Mr NF Oppenheimer because Mr NF
Oppenheimer is interested in shares comprised in the equity share capital
of those entities equal to at least one-fifth of that share capital and
accordingly EOSH, EOSI and Naunton have a responsibility to notify certain
transactions to the Company. The Company is the issuer in relation to whom
this notice is made. The transactions are consequential upon an internal
re-arrangement of the way in which the shareholding interests of the E
Oppenheimer & Son International Limited group are registered and there is
no change to the overall interest of the E Oppenheimer & Son International
Limited Group as a consequence of the rearrangement.
4. On 10 March 2008, EOSH was put into liquidation. In anticipation of this
liquidation:
4.1 On 7 March 2008, Gartland instructed EOSH to transfer 8,097,548
Ordinary Shares held by EOSH as its nominee to EOSI, also as its
nominee;
4.2 On 7 March 2008, Naunton instructed EOSH to transfer 12,517,812
Ordinary Shares held by EOSH as its nominee to EOSI, also as its
nominee.
5. On 10 March, EOSH transferred 6,684,640 shares to EOSI as a consequence of
the liquidation of EOSH.
5.1 On 11 March 2008 Naunton was put into liquidation. As a consequence of
the liquidation Naunton directed EOSI that the 12,517,812 Ordinary
Shares held by EOSI as nominee for Naunton were no longer held by it
in that capacity but were held by EOSI as beneficial owner."
N Jordan
Company Secretary
12 March 2008
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.